All companies, by operating margin
508 companies and 2245 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Operating margin | Quarter |
|---|---|---|---|---|---|
| Not ranked below this line: we do not hold four quarters in a row, so the figure is not the same quantity as the ones above it. | |||||
| – |
|
$51.7B | $277.86 −0.2% | 12% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 LHX L3Harris |
| – | SPCX outside the index SpaceX outside the index Share price: $137.59 −4.4% Q3 FY26 SPCX SpaceX | $1.81T | $137.59 −4.4% | 12% 2 of four quarters in a row 2026: Q2, Q3 | Q3 FY26 SPCX SpaceX |
| – |
|
$158B | $142.85 +1.0% | 12% 2 of four quarters in a row 2027: Q1, Q2 | Q2 FY27 TJX TJX Companies |
| – |
|
$18.8B | $139.58 −0.7% | 11% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 DD DuPont |
| – |
|
$40.6B | $145.26 −0.9% | 11% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 DHI D. R. Horton |
| – |
|
$22.8B | $59.14 −0.4% | 11% 1 of four quarters in a row 2026: Q3 | Q3 FY26 EIX Edison International |
| – |
|
$7.1B | $39.94 +1.9% | 11% 1 of four quarters in a row 2026: Q2 | Q2 FY26 TAP Molson Coors Beverage |
| – |
|
$10.4B | $176.36 −0.1% | 11% 1 of four quarters in a row 2026: Q1 | Q1 FY26 UHS Universal Health Services |
| – |
|
$10.7B | $90.69 −2.8% | 10% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 ALB Albemarle |
| – |
|
$51.4B | $110.25 +0.3% | 10% 1 of four quarters in a row 2025: Q4 | Q4 FY25 ETR Entergy |
| – |
|
$102B | $375.38 +1.2% | 10% 1 of four quarters in a row 2026: Q3 | Q3 FY26 GD General Dynamics |
| – | PSKY S&P 500 Paramount Skydance S&P 500 Share price: $9.78 +0.0% Q2 FY26 PSKY Paramount Skydance | $11.0B | $9.78 +0.0% not requoted | 8% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 PSKY Paramount Skydance |
| – |
|
$15.5B | $102.77 −0.8% | 8% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 SWK Stanley Black & Decker |
| – |
|
$229B | $860.35 −3.1% | 7% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 GEV GE Vernova |
| – |
|
$42.1B | $178.56 +0.4% | 7% 1 of four quarters in a row 2026: Q2 | Q2 FY26 LYV Live Nation Entertainment |
| – |
|
$57.7B | $38.89 +1.2% | 7% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 NKE Nike |
| – |
|
$45.5B | $75.80 −1.5% | 7% 1 of four quarters in a row 2026: Q2 | Q2 FY26 XYZ Block |
| – |
|
$13.8B | $81.33 −2.7% | 6% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 SOLV Solventum |
| – |
|
$36.8B | $139.43 −13.2% | 5% 1 of four quarters in a row 2026: Q3 | Q3 FY26 COIN Coinbase |
| – |
|
$24.8B | $34.33 +2.1% | 5% 1 of four quarters in a row 2026: Q3 | Q3 FY26 DOW Dow |
| – |
|
$76.6B | $87.27 +1.8% | 5% 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 GM General Motors |
| – |
|
$16.6B | $120.46 −1.6% | 5% 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 GPC Genuine Parts |
| – |
|
$295B | $361.14 −5.1% | 5% 1 of four quarters in a row 2026: Q4 | Q4 FY26 PANW Palo Alto Networks |
| – |
|
$116B | $90.56 +0.3% | 4% 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CVS CVS Health |
| – | HUM S&P 500 Humana S&P 500 Share price: $411.47 −1.2% Q1 FY26 HUM Humana | $49.4B | $411.47 −1.2% | 4% 1 of four quarters in a row 2026: Q1 | Q1 FY26 HUM Humana |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.